Pentoxyphilline as a cyclooxygenase (cox-2) inhibitor in experimental sepsis

被引:0
|
作者
Modzelewski, B [1 ]
Janiak, A [1 ]
机构
[1] Med Univ Lodz, Dept Gen Surg, PL-90131 Lodz, Poland
来源
MEDICAL SCIENCE MONITOR | 2004年 / 10卷 / 07期
关键词
sepsis; pentoxyphilline; lipid peroxydation; peritonitis;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: The aim of this study is to assess the impact of pentoxyphilline (PTX) on the pattern of serum concentrations of certain pro-inflammatory cytokines and their soluble receptors in relation to the animal's survival period. Materials/Methods: Diffuse peritonitis was elicited by means of cecal ligation and puncture (CLP) in 45 adult Wistar rats. The pattern of soluble TNF receptor p55 type 1 and p75 type 2 in reference to TNF-alpha and IL-1beta concentration in animals with experimental diffuse peritonitis (EDP) was estimated. All animals were divided into 3 groups. Results: In both groups where animals received medication, the percentage of survival was higher than in the controls. An increase in CRP concentration was observed in all study animals. An increase in TNFalpha concentration was noted during the first 12 hours of the experiment. There was an increase in soluble TNFR p55 concentrations in all study groups until the 24(th) hour of the experiment, then a decrease until the end of the observation period. The concentration of soluble TNF p75 receptor gradually increased over time in all groups. In group I a constant rise of IL-1beta serum concentration was observed. Conclusions: Pentoxyphilline administration in animals in the early stage of diffuse peritonitis causes the TNFalpha serum concentration to decrease, but it does not improve the overall survival period. Late pentoxyphilline administration does not alter the course of diffuse peritonitis in rat.
引用
收藏
页码:BR233 / BR237
页数:5
相关论文
共 50 条
  • [1] Effect of the Selective Cyclooxygenase 2 (COX-2) Inhibitor On the Experimental Acute Pancreatitis
    Do, Jae Hyuk
    Jung, Seung Mun
    Choi, Chang Hwan
    Lee, Hyun Woong
    Oh, Hyoung-Chul
    Kim, Jeong Wok
    Kim, Jae G.
    Chang, Sae Kyung
    GASTROENTEROLOGY, 2009, 136 (05) : A589 - A589
  • [2] APRICOXIB Cyclooxygenase-2 (COX-2) Inhibitor Oncolytic
    Edelman, Martin J.
    DRUGS OF THE FUTURE, 2011, 36 (07) : 503 - 509
  • [3] Cyclooxygenase-2 (COX-2) in acute myocardial infarction: cellular expression and use of selective COX-2 inhibitor
    Saito, T
    Rodger, I
    Shennib, H
    Hu, F
    Tayara, L
    Giaid, A
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2003, 81 (02) : 114 - 119
  • [4] Expression of cyclooxygenase-2(COX-2) in the retina and the effect of COX-2 inhibitor on the mouse model of retinopathy of prematurity
    Kim, CS
    Lee, SN
    Kim, JH
    Park, CJ
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [5] Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2
    McAdam, BF
    Catella-Lawson, F
    Mardini, IA
    Kapoor, S
    Lawson, JA
    FitzGerald, GA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (01) : 272 - 277
  • [6] Expression of cyclooxygenase-2 (COX-2) in experimental glaucoma in rats
    Kwong, JM
    Caprioli, J
    Lam, TT
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U227 - U227
  • [7] Radiosensitization of human glioma cells by cyclooxygenase-2 (COX-2) inhibition: Independent on COX-2 expression and dependent on the COX-2 inhibitor and sequence of administration
    Kuipers, Gitta K.
    Slotman, Ben J.
    Wedekind, Laurine E.
    Stoter, T. Rianne
    Van Den Berg, Jaap
    Sminia, Peter
    Vincent, M.
    Lafleur, M.
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2007, 83 (10) : 677 - 685
  • [8] Cyclooxygenase-2 (COX-2) inhibitor stimulates pancreatic cancer growth
    Eibl, G
    Reber, HA
    Wente, MN
    Hines, OJ
    GASTROENTEROLOGY, 2002, 122 (04) : A489 - A490
  • [9] Increased cyclooxygenase-2 (COX-2) expression in acute myocardial infarction: Therapeutic target of a selective COX-2 inhibitor
    Saito, T
    Rodger, IW
    Hu, F
    Tayara, L
    Giaid, A
    CIRCULATION, 2000, 102 (18) : 271 - 271
  • [10] Expression of cyclooxygenase 2 (COX-2) in human glioma and in Vitro inhibition by a specific COX-2 inhibitor, NS-398
    Joki, T
    Heese, O
    Nikas, DC
    Bello, L
    Zhang, JP
    Kraeft, SK
    Seyfried, NT
    Abe, T
    Chen, LB
    Carroll, RS
    Black, PM
    CANCER RESEARCH, 2000, 60 (17) : 4926 - 4931